Can Ozempic Maker Novo Nordisk Keep Up Its Momentum?
Podcast: WSJ What’s NewsPublished On: Thu May 02 2024
Description: A.M. Edition for May 2. Danish pharmaceutical giant Novo Nordisk upped its full-year guidance today as it reported continued strong demand for its blockbuster weight-loss and diabetes drugs. Barclays analyst Emily Field discusses where the drugmaker could go from here. Plus, Exxon Mobil reaches an agreement to close its $60 billion merger with Pioneer. And TikTok strikes a licensing deal to return Universal Music artists to the platform. Luke Vargas hosts. Listening on Google Podcasts? Here's our guide for switching to a different podcast player. Learn more about your ad choices. Visit megaphone.fm/adchoices
The note was deleted
The note was saved
Your message was sent